CURE Pharma gets USDEA nod to develop cannabinoid-based products

CURE Pharmaceutical, an innovative drug delivery and development company, has secured a new registration with the Drug E...

November 28, 2018 | Wednesday | News
Philip Gutry appointed as Chief Business Officer by Kronos Bio

U.S. based Kronos Bio has announced that it has appointed Philip Gutry as its Chief Business Officer. In this newly cre...

November 28, 2018 | Wednesday | News
Merck Foundation underscores partnership with Health ministry of C.A.R.

Merck Foundation, the philanthropic arm of Merck Germany underscored their commitment to build healthcare capacity in th...

November 28, 2018 | Wednesday | News
Aspen launches novel HIV drug combination

Aspen Pharmacare, South Africa’s leading JSE-listed pharmaceutical company, is pleased to announce the launch of E...

November 28, 2018 | Wednesday | News
Axovant strengthens team to support gene therapy pipeline

Clinical-stage gene therapy company Axovant has announced the addition of five senior team members to strengthen its exp...

November 27, 2018 | Tuesday | News
DRC initiates first-ever multi-drug Ebola trial

First-ever multi drug trial for an Ebola treatment has been announced by The Ministry of Health of the Democratic Republ...

November 27, 2018 | Tuesday | News
REGENXBIO, Rocket Pharma partner for Danon disease

REGENXBIO Inc, a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of...

November 26, 2018 | Monday | News
Cobra, Pall, Cell and Gene Therapy Catapult win £1.5M Innovate UK grant

Singapore –Cobra Biologics, an international contract development and manufacturing organization (CDMO) ...

November 26, 2018 | Monday | News
Santhera to acquire exclusive sub-license of Vamorolone

Santhera Pharmaceuticals which is Swiss specialty pharmaceutical company focused on the development and commercializatio...

November 26, 2018 | Monday | News
Altus Capital acquires ChoiceSpine

An investment firm focused on the North American manufacturing sector, Altus Capital Partners has announced that it has ...

November 26, 2018 | Monday | News
Eurofins to distribute Synthego's Genome Engineering products

Synthego, the leading provider of genome engineering products, and Eurofins Genomics, a global leader in bioanalytical t...

November 23, 2018 | Friday | News
Mylan recalls batches of blood-pressure drug containing valsartan

Singapore - Mylan N.V. announced that its U.S. based Mylan Pharmaceuticals business is conducting a voluntary nationwide...

November 22, 2018 | Thursday | News
Eureka Therapeutics publicizes preclinical study validating ARTEMIS Platform

Eureka Therapeutics has announced publication in Cell Discovery validating its ARTEMIS antibody-TCR (AbTC...

November 22, 2018 | Thursday | News
Brickell Biotech appoints Robert Brown as CEO

Notable leadership change comes as Brickell prepares to progress its lead product candidate, sofpironium bromide, to Pha...

November 21, 2018 | Wednesday | News
NIH explains behavioral reaction to painful experiences

Researchers at the National Centre for Complementary and Integrative Health (NCCIH), part of the National Institutes of ...

November 21, 2018 | Wednesday | News
3D images from world's first full-body scanner

Images from the world's first full-body 3D medical scanner named EXPLORER have been released. This scanner is developed ...

November 21, 2018 | Wednesday | News
LEO Pharma, PellePharm enter into $760 M collaboration

Danish dermatology specialists LEO Pharma and California based company PellePharm has announced a strategic development ...

November 21, 2018 | Wednesday | News
Handful pharma companies developing bulk of urgently needed medicines: Study

The development of new medical products that are considered the highest priority for people in developing countries is h...

November 21, 2018 | Wednesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls